Previous Close | 0.8101 |
Open | 0.8302 |
Bid | 0.7703 x 100 |
Ask | 0.8455 x 100 |
Day's Range | 0.8000 - 0.8304 |
52 Week Range | 0.5390 - 1.3400 |
Volume | |
Avg. Volume | 407,946 |
Market Cap | 60.58M |
Beta (5Y Monthly) | 2.34 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Is it a good or bad thing when a stock experiences a golden cross technical event?
Aligos Therapeutics ( NASDAQ:ALGS ) Full Year 2023 Results Key Financial Results Revenue: US$15.5m (up 12% from FY...
Here is how Aligos Therapeutics, Inc. (ALGS) and Allogene Therapeutics (ALLO) have performed compared to their sector so far this year.